Ethanol ablation for the treatment of benign thyroid nodules - 20/06/22
, Latoya A. Stewart a, Catherine McManus b, James A. Lee b, Jennifer H. Kuo bAbstract |
Background |
Ethanol ablation (EA) is a non-surgical option for the treatment of benign cystic thyroid nodules. This study summarizes our preliminary experience with the efficacy and safety of EA.
Methods |
A retrospective analysis was performed of patients undergoing EA for symptomatic, benign, cystic and predominantly cystic (≥75%) thyroid nodules. Baseline nodule volume, cosmetic scores, and symptom scores were assessed, as well as volume reduction ratio (VRR), cosmetic and symptom scores at post-procedure months 1, 3, 6, and 12.
Results |
31 patients underwent an uncomplicated EA for a single cyst with an average volume of 21.3 cc (range: 1.7–101.4 cc). Follow-up was limited by the COVID-19 pandemic. Mean nodule VRRs were 66 ± 20% (1 m, n = 17), 87 ± 15% (3 m, n = 9), 72 ± 20% (6 m, n = 7), and 78% (12 m, n = 3). Mean symptom and cosmetic scores decreased concurrently post-procedure.
Conclusion |
EA is a safe, effective option for benign cystic and predominantly cystic thyroid nodules.
Le texte complet de cet article est disponible en PDF.Highlights |
• | 31 patients underwent ethanol ablation as an office procedure. |
• | Nodule size decreased significantly after a single ethanol ablation. |
• | Patients' compressive and cosmetic symptoms decreased concurrently. |
• | Ethanol ablation is a safe, repeatable procedure for benign, cystic thyroid nodules. |
Keywords : Thyroid nodule, Thyroid cyst, Ethanol ablation, Percutaneous ethanol injection
Plan
Vol 224 - N° 1PB
P. 408-411 - juillet 2022 Retour au numéro
Article précédent
- The impact of patient age on practice patterns and outcomes for primary hyperparathyroidism
- Whitney Sutton, Joseph K. Canner, Jessica B. Shank, Abbey L. Fingeret, Shkala Karzai, Dorry L. Segev, Jason D. Prescott, Aarti Mathur
- Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer
- Whitney Sutton, Philip K. Crepeau, Joseph K. Canner, Shkala Karzai, Dorry L. Segev, Aarti Mathur
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?